REMS
Absorption: Well absorbed following oral administration (97%)
Distribution: Unknown.
Protein Binding: 95%.
Half-Life: Tablets: 10.4 hr; modified-release tablets: 16 hr.
Contraindicated in:
Use Cautiously in:
Endo: hypoglycemia
GI: ↑liver enzymes, abdominal pain, diarrhea, dyspepsia, nausea, vomiting
Derm: photosensitivity, rash
Drug-drug:
Lab Test Considerations:
Toxicity and Overdose: